What advantage does loratadine have compared with traditional antihistamines such as diphenhydramine?

Choice A reason: Drowsiness is not a systemic effect of inhaled albuterol, a beta-2 agonist. Albuterol stimulates beta-adrenergic receptors, increasing cyclic AMP, which can cause CNS stimulation, not sedation. Drowsiness is more associated with antihistamines or other CNS-depressant drugs, not bronchodilators like albuterol.

Choice B reason: Bradycardia is unlikely with albuterol, which activates beta-2 receptors and, to a lesser extent, beta-1 receptors in the heart, potentially causing tachycardia. Systemic absorption of inhaled albuterol can increase heart rate, not decrease it, as it stimulates sympathetic activity, making this incorrect.

Choice C reason: Heartburn is not a recognized systemic effect of inhaled albuterol. While gastrointestinal irritation may occur with oral beta-agonists, inhaled albuterol has minimal systemic absorption, targeting airway smooth muscle. Its side effects are primarily cardiovascular or neurological, not gastrointestinal, making this an incorrect choice.

Choice D reason: Palpitations are a possible systemic effect of inhaled albuterol due to its beta-adrenergic stimulation. Even with low systemic absorption, albuterol can stimulate cardiac beta-1 receptors, increasing heart rate and causing palpitations. This is a known side effect, particularly in sensitive patients or with overuse.

Choice A reason: Fibric acid derivatives, like fenofibrate, lower triglycerides by activating PPAR-alpha, reducing VLDL production. They are not commonly associated with myopathy, though gastrointestinal upset or liver enzyme elevation may occur. Myopathy is more characteristic of statins, making this an incorrect class for monitoring.

Choice B reason: Niacin lowers lipids by inhibiting VLDL synthesis but is not significantly linked to myopathy. Its primary side effects include flushing and hepatotoxicity due to prostaglandin release and metabolic stress. Muscle pain is a hallmark of statins, not niacin, making this incorrect.

Choice C reason: Bile acid sequestrants, like cholestyramine, bind bile acids, reducing cholesterol absorption. They cause gastrointestinal side effects like constipation but not myopathy. Their mechanism does not affect muscle tissue, unlike statins, which inhibit HMG-CoA reductase, making this class irrelevant for myopathy monitoring.

Choice D reason: Statins, like simvastatin, inhibit HMG-CoA reductase, reducing cholesterol synthesis. They can cause myopathy by disrupting muscle cell membranes or mitochondrial function, leading to muscle pain or rare rhabdomyolysis. Monitoring for myopathy is critical, as it can progress to severe muscle damage, making this the correct class.